The options are neoadjuvant, adjuvant, or no chemotherapy at all: further data is needed.
作者信息
Sugarbaker Paul H, Van der Speeten Kurt
机构信息
MedStar Washington Hospital Center, Washington, DC, USA.
Department of Surgery, Hospital Oost-Limburg, Genk, Belgium.
出版信息
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S214-S215. doi: 10.21037/jgo-2020-19.
Abstract
摘要
相似文献
1
The options are neoadjuvant, adjuvant, or no chemotherapy at all: further data is needed.选择包括新辅助化疗、辅助化疗或根本不进行化疗：还需要更多数据。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S214-S215. doi: 10.21037/jgo-2020-19.
2
Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study.新辅助化疗与辅助化疗治疗膀胱癌的比较：一项全国性队列研究。
J Cancer Res Clin Oncol. 2022 Nov;148(11):3135-3144. doi: 10.1007/s00432-022-03926-1. Epub 2022 Jan 21.
3
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.BRCA 突变的三阴性乳腺癌患者的辅助化疗与新辅助化疗。
Breast Cancer Res Treat. 2018 Jul;170(1):101-109. doi: 10.1007/s10549-018-4727-9. Epub 2018 Feb 22.
4
Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?肌肉浸润性膀胱癌的新辅助治疗和辅助治疗：我们目前的进展如何？
Arch Esp Urol. 2020 Dec;73(10):971-985.
5
The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy.新辅助放化疗后ypT0-2N0直肠癌患者辅助化疗的作用。
Front Oncol. 2024 Feb 9;14:1338098. doi: 10.3389/fonc.2024.1338098. eCollection 2024.
6
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.胰腺癌的新辅助化疗和辅助化疗
Langenbecks Arch Surg. 2018 Dec;403(8):917-932. doi: 10.1007/s00423-018-1724-8. Epub 2018 Nov 5.
7
Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?新辅助化疗后延迟手术：所有非转移性高级骨盆骨肉瘤患者都需要吗？
Clin Orthop Relat Res. 2018 Nov;476(11):2177-2186. doi: 10.1097/CORR.0000000000000387.
8
[Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].奥沙利铂联合卡培他滨或奥沙利铂联合S-1新辅助化疗治疗进展期胃癌的安全性和有效性
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):138-144. doi: 10.3760/cma.j.cn.441530-20200721-00433.
9
[Principles for adjuvant and neoadjuvant chemotherapy].[辅助化疗和新辅助化疗原则]
Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:333-7.
10
Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.新辅助化疗与辅助顺铂-紫杉醇方案治疗 FIGO 分期 IB3 和 IIA2 宫颈癌的疗效分析。
Med Sci Monit. 2023 Dec 8;29:e940545. doi: 10.12659/MSM.940545.
本文引用的文献
1
Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research.除细胞减灭术和腹腔热灌注化疗外，用于结直肠腹膜转移的全身治疗：临床研究和转化研究的最新见解
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S206-S213. doi: 10.21037/jgo-20-133.
Zotero 插件